Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
VIRUSÄHNLICHE PARTIKELKONJUGATE ZUR BEHANDLUNG VON TUMOREN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2014845738
EP Publication Number
3046583
E-Number
1095830
Language
EN
PCT Number
US14056412
Publication Date
27.07.2016 A
13.02.2019 B1
Registration Date
13.02.2019
AT Publication Date
15.02.2019
Application Date
18.09.2014
Registration Number
-
Priorities
18.09.2013
US
201361879627 P
IPC
A61K 39/42 20060101AFI20170329BHEP
Maximum Duration of Protection
18.09.2034
Owner
Aura Biosciences, Inc.85 Bolton Street Cambridge, MA 02140US
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services6011 Executive Boulevard Suite 325 MSC 7660 Bethesda, Maryland 20892-7660US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
DE LOS PINOS, Elisabet144 Pleasant Street Brookline, MA 02246US
SCHILLER, John, T.9630 Dewmar Lane Kensington, MD 20895US
KINES, Rhonda, C.4114 Davis Pl. NW Washington, DC 2007US
MACDOUGALL, John46 Kimball Beach Road Hingham, MA 02043US